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Abstract
The relevance of innate immune responses to Plasmodium falciparum infection,
in particular the central role of natural killer (NK) cell-derived interferon gamma
(IFN-γ), is becoming increasingly recognised. Recently, it has been shown that
IFN-γ production in response to P. falciparum antigens is in part regulated by killer-
cell immunoglobulin-like receptor (KIR) genes, and a study from malaria-exposed
Melanesians suggested an association between KIR genotypes and susceptibility
to infection. This prompted us to determine and compare the frequencies of 15
KIR genes in Gambian children presenting with either severe malaria (n = 133)
or uncomplicated malaria (n = 188) and in cord-blood population control samples
(n = 314) collected from the same area. While no significant differences were
observed between severe and uncomplicated cases, proportions of individuals with
KIR2DS2+C1 and KIR2DL2+C1 were significantly higher among malaria cases
overall than in population control samples. In an exploratory analysis, activating
KIR genes KIR2DS2, KIR3DS1 and KIR2DS5 were slightly higher in children in
disease subgroups associated with the highest mortality. In addition, our data suggest
that homozygosity for KIR genotype A might be associated with different malaria
outcomes including protection from infection and higher blood parasitaemia levels in
those that do get infected. These findings are consistent with a probable role of KIR
genes in determining susceptibility to malaria, and further studies are warranted in
different populations.
Introduction
Infection with the malaria parasite Plasmodium falciparum
can result in asymptomatic parasite carriage, an uncomplicated
febrile disease or a potentially life-threatening illness. Apart
from clinical immunity that gradually develops with repeated
exposure (1), human genetic variation influences clinical out-
come in response to parasite encounter (2). Epidemiological
data from Kenya have indicated that about 25% of the risk
of being infected with malaria parasites can be attributed to
human genetic variation (3).
Natural killer (NK) cells are a key component of innate
immunity. They kill their targets (diseased cells) by means
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of cytotoxic activity (4) and production of inflammatory
cytokines (5). Traditionally, activation of NK cells is explained
by the ‘missing self’ hypothesis (6), where the lack of
major histocompatibility complex (MHC) class I molecules
on infected or malignant cells is sensed by NK cell surface
receptors, or activating NK cell receptors interact with stress-
induced molecules on the surface of altered cells (4). While
most pathogens can activate NK cells, down-regulation of
MHC class I molecules is not a common feature of many
infectious diseases, and it is now increasingly recognised
that most pathogens predominantly activate NK cells via an
indirect pathway, with activating signals (both soluble and
contact-dependent) being provided by accessory cells, such as
dendritic cells, macrophages and/or monocytes (7).
In protozoan infections, rapid production of interferon
gamma (IFN-γ) rather than cytotoxicity is the major con-
tribution of NK cells to host defence (8). For malaria, in
particular, there is clear evidence that NK-cell-derived IFN-γ,
and not cytotoxicity, contributes to protection (9). Human
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NK cells in peripheral blood mononuclear cell (PBMC) cul-
tures produce IFN-γ within 6 h of parasite encounter (10),
which is dependent on the presence of accessory cells.
Within an individual the magnitude of the NK cell IFN-
γ response is associated with the strength of the signal
provided by the accessory cells (11). However, when com-
pared between different individuals, the degree and mag-
nitude of NK-cell-specific IFN-γ production in response to
P. falciparum displays considerable heterogeneity (10, 12)
and was shown to be significantly associated with killer-cell
immunoglobulin-like receptor (KIR) genotypes in two stud-
ies (13, 14). Thus, in addition to the strength of the signal
received from accessory cells, KIR genotypes seem to regu-
late the degree of IFN-γ produced by KIR-positive NK cell
populations.
NK cells can be subdivided further into two subsets,
CD56bright and CD56dim expressing cells (15). While
CD56bright cells produce more IFN-γ than CD56dim cells,
CD56dim cells represent about 80% of the NK cell popula-
tion (16), thus the vast majority of IFN-γ producing NK cells
are the CD56dim population (14). Interestingly, CD56bright
cells are KIR negative, whereas the majority of CD56dim
cells express KIRs that are highly polymorphic (16, 17). This
makes it plausible that KIR–MHC class I interactions might
regulate the magnitude of IFN-γ produced by KIR+CD56dim
cells.
KIR molecules are glycoproteins encoded by a diverse and
compact set of genes on chromosome 19. They are expressed
on specialised lymphoid cells mainly NK cells and a subpop-
ulation of γδ T cells and some memory αβ T cells (18). The
family comprises 15 functional genes (KIR2DL1, KIR2DL2,
KIR2DL3, KIR2DL4, KIR2DL5A, KIR2DL5B, KIR2DS1, KIR2
DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1, KIR3DL2,
KIR3DL3 and KIR3DS1 ) and 2 pseudogenes (KIR2DP1 and
KIR3DP1 ). The expression and function of each of these
genes influence the expression and function of other members
of the gene family (19). KIR molecules are structurally simi-
lar with two or three extracellular domains, a transmembrane
region and a cytoplasmic tail but can be divided on functional
grounds into activating and inhibitory receptors based on the
length and composition of their cytoplasmic tails (20). NK
cell-mediated activity is dependent on a fine balance between
the strengths of the inhibitory and activating signals induced
by KIR molecules on the NK cell surface.
Although located on different chromosomes and therefore
segregating separately, the coevolving human leukocyte anti-
gen (HLA) and KIR systems (21, 22) encode for molecules
with crucial roles in immune modulation of infectious diseases
including malaria (23–25). Certain HLA class I molecules are
ligands for KIRs and their interactions regulate NK cell activ-
ity in modulating disease outcomes (23, 26–33). However,
the interaction between HLA and KIR genes in malaria has not
been fully established even though certain HLA class I and II
alleles (34, 35), and KIR genotypes have independently been
associated with malaria clinical outcomes (36).
Whilst there is accumulating evidence favouring an impor-
tant role of NK cells in P. falciparum infection, only a few
studies have investigated the role of KIRs in malaria. A study
that compared KIR genotypes in Melanesians with and with-
out malaria parasitaemia found evidence for an increased
number of activating KIR genes in parasitaemic individu-
als (36). This suggests that KIR diversity may shape the innate
response to malaria parasites and probably influences disease
outcome. In this study, we compared the proportion of indi-
viduals positive for different combinations of activating and
inhibitory KIR genes among Gambian children with severe
or uncomplicated forms of malaria, and cord-blood popula-
tion control samples to assess whether individual KIR genes
or genotypes are associated with the occurrence of disease or
parasitaemia levels. Given that epidemiological findings have
in the past implicated individual HLA class I alleles (e.g. HLA-
B*53 ) (37) with differential susceptibility to malaria infection,
we also investigated whether certain KIR–HLA compound
genotypes are associated with malaria outcomes.
Materials and methods
Study populations
DNA samples were obtained from buccal swabs collected
from Gambian children with uncomplicated malaria (>5000
parasites/μl, a temperature of >37.5 ◦C; UM) and severe
malaria [using modified World Health Organization (WHO)
criteria (38); SM], who were enrolled between 2006 and 2009
into a study of the pathogenesis of severe malaria described
in more detail elsewhere (39, 40). For each patient, a thin
and a thick smear were prepared and Giemsa stained. The
diagnosis was made by slide microscopy of the thick film
at the health centre. The thin smears were subsequently
read in the research laboratory, and parasitaemia counts per
microlitre were adjusted for the actual number of red blood
cells (RBCs) obtained from the full blood count, collected
at the same time. Severe disease was further subdivided into
severe anaemia (SA), defined as Hb < 6 g/dl; severe respi-
ratory distress (SRD) defined as serum lactate >7 mmol/l;
cerebral malaria (CM) defined as a Blantyre coma score ≤2
in the absence of hypoglycaemia or hypovolaemia, with the
coma lasting for at least 2 h; and severe prostration (SP)
defined as inability to sit unsupported (children > 6 months)
or inability to suck (children ≤ 6 month). For some anal-
yses, different entities of severe diseases were stratified
according to increasing disease severity, ranging from UM<
SP< SA< CM< SRD< CM+SRD, consistent with a large
study from Kenya showing that mortality increases in this
order (41). DNA extracted from cord-blood samples of Gam-
bian neonates collected from health-care facilities of the same
area for a different study (42) served as population control
samples. Both studies were approved by the Joint Gambian
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Table 1 Characteristics of the study participants
n
Mortality
(%)
Age (GM,
years) 95% CI
Female
(%)
Severe 133 6.0 4.4 4.01–4.72 42.5
CM+SRD 14 28.6 4.3 3.42–5.38 50.0
SRD 16 18.8 4.7 3.66–5.99 33.3
CM 23 0.0 4.3 3.59–5.06 38.9
SA 11 0.0 2.8 2.02–3.95 45.5
SP 69 1.5 4.6 4.11–5.22 43.8
Uncomplicated 188 0.0 6.3 5.80–6.90 43.1
Cord blood (population
control)
314 — — — 50.2
CI, confidence interval; CM, cerebral malaria; GM, geometric mean;
n, number of individuals; SA, severe anaemia; SP, severe prostration;
SRD, severe respiratory distress.
Government/MRC Ethics Committee (GGMEC), and written
informed consent was obtained from a parent or legal guardian
prior to sample collection. For the work described herein, a
separate approval was obtained from the GGMEC.
In total, DNA samples from 635 individuals were analysed
in this study (314 cord-blood samples, 188 uncomplicated
and 133 severe malaria cases). Further demographic details
on study participants are given in Table 1.
KIR typing
Genomic DNA samples were typed by the polymerase chain
reaction-sequence-specific-priming (PCR-SSP) technique as
described elsewhere (43) to detect the presence of 14 KIR
genes: 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3,
2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, and 1 pseudogene
KIR2DP1. Briefly, this technique entailed the use of specific
primers to amplify two segments of different sizes from the
same KIR gene if present. The fragments were then stained
with ethidium bromide during electrophoresis in 2% agarose
gel. Specific bands were visualised on a UV light box, an
electronic picture of the gel was taken and scored for the
presence or absence of specific bands. Discrepant results (i.e.
one primer pair positive while the other is negative) were
repeated and the gene considered present if one of the reaction
pairs was consistently positive. The use of two pairs of primers
to detect the same gene was to limit false negative results
as much as we can in this population that has not been
typed for KIR genes before. The absence of specific bands
on both reactions was confirmed by repeating the typing to
make sure that the gene was actually absent. Each reaction
also contained a pair of internal control primers amplifying a
796-bp fragment from the third intron of HLA-DRB1 gene to
check for PCR efficiency.
HLA class I typing
Genotyping for HLA class I (HLA-B and -C) alleles was
performed using sequence-based techniques on 148 and 382
samples, respectively as described elsewhere (33). Briefly, a
pair of locus-specific primers was used to amplify each locus
and two other pairs of internal primers were used to sequence
exons 2 and 3 in both directions using the BigDye Terminator
version 3.1 technologies (Applied Biosystems, Foster City,
CA). The software ‘ASSIGN’ (Conexio Genomics, Australia)
was used to analyse all sequence traces.
Statistical analysis
The observed frequency for each KIR gene was deter-
mined by direct counting and verified using STATA version
9.2 (Stata Corporation, TX) and PASW Statistics 18 (SPSS,
Inc., Chicago, IL). This corresponded to the proportion of
individuals that carried the gene of interest in the group
under investigation. HLA class I allele and genotype fre-
quencies were computed with the same statistical packages.
The centromeric (cen) and telomeric (tel) motifs of each
KIR genotype were assigned using a modified technique
derived from Cooley et al. (44) and Pyo et al. (45). Their
frequencies and those of HLA and KIR genes, as well as
KIR–HLA compound genotypes were determined and com-
pared across groups (population control, uncomplicated and
severe malaria) using chi-squared or Fisher’s exact tests as
appropriate. P -values of <0.05 were considered significant.
Correction for multiple comparisons was performed using the
Bonferroni method. In addition, adjustment for ethnicity was
performed for comparisons between the cases and controls.
Differences in parasitaemia levels for groups of individuals
with varying ratios of inhibitory over activating KIR genes
were examined using one-way analysis of variance (ANOVA) on
log transformed parasitaemia data, with a post-test for linear
trend.
The statistical packages STATA version 9.2 (Stata Corpora-
tion, TX), PASW Statistics 18 (SPSS, Inc., Chicago, IL) and
PRISM version 5.04 (GraphPad Software Inc., CA) were used
to perform all statistical analyses.
Results
The frequency of individual KIR genes does not differ
between ethnicities
All 15 KIR genes investigated were present in the study popu-
lation. Recognising the ethnic diversity of this population, we
stratified the observed frequency of each KIR gene according
to the major ethnic groups. Data for self-reported ethnicity
were available for 94% of all samples tested. Table 2 shows
that the proportions of individuals carrying any of the KIR
genes were similar across all ethnic groups. Homogeneity
of frequencies among different ethnic groups was formally
assessed using the chi-squared distribution or Fisher’s exact
test and no significant differences were observed. This indi-
cates that ethnic differences are not major determinants of the
frequencies here.
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Table 2 KIR frequencies in the study population stratified by ethnicitya
KIR gene
Mandingo
(199) (%)
Wollof
(88) (%)
Fula (137)
(%)
Jola (89)
(%)
Serere
(29) (%)
Others
(57) (%) P value
2DL1 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
2DL2 76.9 69.3 73.7 78.7 58.6 84.2 0.090
2DL3 90.0 90.9 88.3 83.2 89.7 77.2 0.097
2DL4 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
2DL5 60.3 53.4 59.1 56.2 55.2 64.9 0.773
2DS1 21.1 23.9 21.2 24.7 24.1 26.3 0.944
2DS2 59.8 56.8 58.4 64.0 51.7 70.2 0.492
2DS3 43.2 42.1 44.5 49.4 31.0 56.1 0.266
2DS4 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
2DS5 28.1 25.0 32.8 25.8 34.5 42.1 0.229
3DL1 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
3DL2 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
3DL3 100.0 100.0 100.0 100.0 100.0 100.0 n.a.
3DS1 11.1 5.7 7.3 7.9 13.8 10.5 0.578
2DP1 99.5 98.9 100.0 98.9 96.6 96.5 0.194 F
n.a., not applicable.
aInformation on ethnicity was available for 94% of all samples. Numbers in parenthesis represent the number of individuals per ethnic group.
Homogeneity of the frequencies of KIR genes among different ethnic groups was assessed using the chi-squared test or Fisher’s exact test (F) in the
case of 2DP1.
Effect of KIR gene in severe and uncomplicated malaria
We next investigated whether proportions of individuals
with each of these KIR genes differed between severe and
uncomplicated malaria cases or between malaria cases and
population controls. Figure 1 shows the carrier frequency for
each KIR gene in the two disease groups and population
control samples, and Table S1 (Supporting Information) shows
the proportion of carriers by disease entities. In addition
to the framework genes KIR2DL4, 3DL2 and 3DL3, three
other genes KIR2DL1, 2DS4 and 3DL1 were present in all
individuals. Overall, proportions of individuals with each of
the inhibitory KIR genes exceeded 75% with the exception of
KIR2DL5 (58.9%) while those carrying any of the activating
KIR genes (except KIR2DS2 ) ranged from 9.5% to 45.4%.
Assessment of the homogeneity of proportions positive for
each of the KIR genes across groups identified significant
differences for KIR2DL2, KIR2DS2, KIR3DS1 and the pseu-
dogene KIR2DP1, with their respective P -values being 2 ×
10−7, 2.7 × 10−5, 2.7 × 10−2 (chi-squared test), and 8 × 10−3
(Fisher’s exact test), of which only KIR2DL2 and KIR2DS2
remained significant after Bonferroni correction for multiple
comparison (corrected P - values 3 × 10−6 and 4.05 × 10−4,
respectively). Further analysis showed that none of the fre-
quencies differed between uncomplicated and severe malaria
cases. However, when all cases (severe and uncomplicated
malaria combined) were compared with cord-blood popula-
tion samples, KIR2DL2, KIR2DS2 and KIR3DS1 were signifi-
cantly more common in cases than in cord-blood samples (chi-
squared test, P = 1 × 10−6, 1.2 × 10−5, 8.6 × 10−3, respec-
tively), while the pseudogene KIR2DP1 was slightly less com-
mon in cases (Fisher’s exact test, P = 0.03). After correction
0
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Figure 1 Killer-cell immunoglobulin-like receptor (KIR) frequency in
uncomplicated and severe malaria cases, and in cord-blood population
control samples. Next to the pseudo gene KIR2DP1, the frequencies
of inhibitory and activating KIR genes are shown in decreasing
and increasing frequencies, respectively. Differences that remained
significant after Bonferroni correction for multiple comparisons are
indicated with *.
for multiple comparisons using the Bonferroni method only
KIR2DL2 and KIR2DS2 genes remained significantly more
frequent in malaria cases than in population controls (cor-
rected P < 0.0001 for both comparisons), while the result
for KIR3DS1 and the pseudogene KIR2DP1 became non-
significant (corrected P = 0.129 and P = 0.45, respectively).
Relationship between centromeric and telomeric KIR
motifs and genotypes with malaria
The typing technique used in this study (PCR-SSP) allowed
us to detect the presence of inhibitory and activating KIR
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genes but not their different alleles. On the basis of SSP
typing, two KIR genotypes (A and B) have been defined
depending on the number and type of haplotypes making the
genotype (46). Each KIR genotype is made up of two parts
(one centromeric and one telomeric motif) separated by a
recombination hot spot area upstream of KIR2DL4 gene. KIR
genotype A has a uniform gene content with its centromeric
part containing specific genes such as KIR2DL3, 2DL1 and
2DP1, in addition to the frame work genes 3DL3 and 3DP1.
The telomeric part of KIR genotype A is marked by the pres-
ence of KIR3DL1 and 2DS4 and the ubiquitous KIR2DL4
and KIR3DL2 (frame work genes). Individuals homozygous
for KIR genotype A have two copies of A haplotypes [i.e. two
copies of centromeric A motifs (c-A/A) and two telomeric A
motifs (t-A/A)].
In contrast to the conserved nature of genotype A in terms
of gene content, KIR genotype B is highly polymorphic in
gene content. Genotype B is a combination of activating
and inhibitory KIR genes including those found in genotype
A. The number of specific genes found at the centromeric
end of B genotypes is variable including KIR2DS2, 2DL2,
2DL5, 2DS3 and 2DS5, in addition to the framework genes
3DL3 and 3DP1. However, telomeric B motifs are specifically
identified with the presence of KIR3DS1 and 2DS1 genes in
addition to 2DL4 and 3DL2 present in most motifs.
We adopted the recent techniques and terminologies used
by Cooley et al. (44) and Pyo et al. (45) to assign centromeric
(cen) and telomeric (tel) motifs and genotypes to each of our
samples. The most frequent KIR genotypes included c-AB2/
t-AA (17.32%) and c-AA/t-AA (16.7%) (not shown). Indi-
viduals with c-AB2/t-AA genotype are heterozygotes for
A and B2 motifs at the centromeric part while their KIR
genes at the telomeric end all belong to KIR haplotype
A (Figure S1). On the other hand, carriers of c-AA/t-AA
genotype are homozygotes for A haplotypes meaning they
lack all activating KIR genes except KIR2DS4 (Figure S1).
Analysis of KIR centromeric and telomeric genotype data
(shown in Table 3, and Figure S1) did not show significant
differences between uncomplicated and severe malaria cases.
Similarly, exploratory analyses comparing KIR genotype fre-
quencies amongst different disease entities (uncomplicated
malaria, SP, SA, CM, SRD and CM+SRD) showed no signifi-
cant associations between KIR genotypes and malaria severity
(Table S1). However, comparing the three groups together
showed a significant imbalance in the distribution of indi-
viduals homozygous for centromeric A motifs, with a higher
proportion of carriers found in the cord-blood population con-
trol group than in cases (P = 0.001; adjusted for ethnicity
and multiple comparisons P = 0.007). An opposite effect was
observed for heterozygote (c-A/B) carriers (Table 3), with a
higher proportion of carriers found amongst malaria cases
(P = 0.002, adjusted for ethnicity and multiple comparisons
P = 0.021). No such differences were seen with telomeric
genotypes.
The proportion of individuals homozygous for KIR geno-
type A varied significantly amongst the three groups (Table 3).
Whilst no significant difference was observed between
severe and uncomplicated cases, the proportion of individ-
uals carrying the A/A genotype in the population control
group was almost double that in the infected group (21.0%
vs 12.5%, respectively, P = 0.004; adjusted for ethnicity
and multiple comparisons P = 0.012), suggesting that hav-
ing two copies of haplotype A may be protective against
malaria infection. An interesting observation was that none
of the 14 children with CM+SRD, considered to be the
most critically ill patients, was homozygous for KIR geno-
type A, while a substantial proportion of children with less
severe forms of malaria were homozygous for genotype
A (11%, 16%, 18% and 26% in UM, SP, SA and CM,
respectively). Given the small number of individuals per
Table 3 Effect of centromeric and telomeric motifs and KIR genotypes on malaria
Genotype
Uncomplicated
malaria n (%)
Severe
malaria n
(%)
Combined
cases n
(%)
Pop
control n
(%) PA PB PC OR (95% CI)
Centromeric
c-A/A 20 (10.6) 20 (15.0) 40 (12.46) 69 (22.0) 0.004 0.001 0.007 0.5 (0.32–0.79)
c-B/B 31 (16.5) 19 (14.3) 50 (15.58) 56 (17.8) 0.652 0.446 ns 0.92 (0.59–1.44)
c-A/B 137 (72.9) 94 (70.7) 231 (71.96) 189 (60.2) 0.007 0.002 0.021 1.61 (1.14–2.29)
Telomeric
t-A/A 135 (71.8) 90 (67.7) 225 (70.09) 231 (73.6) 0.448 0.331 ns 1.01 (0.7–1.45)
t-A/B 53 (28.2) 43 (32.3) 96 (29.91) 83 (26.4) 0.448 0.331 ns 0.99 (0.69–1.43)
KIR
A/A 20 (10.6) 20 (15.0) 40 (12.46) 66 (21.0) 0.009 0.004 0.012 0.53 (0.34–0.84)
B/x 168 (89.4) 113 (85.0) 281 (87.54) 248 (79.0) 0.009 0.004 0.012 1.87 (1.19–2.96)
Bx, non-A centromeric or telomeric part that is different from known B motifs; CI, 95% confidence intervals; n, number of individuals positive for the
genotype of interest; P, chi-squared P-values comparing (A) all groups, (B) combined cases (uncomplicated and severe malaria) vs population controls,
and (C) as for B above but corrected for multiple comparisons by the Bonferroni approach after adjustment for ethnicity; ns, non-significant; OR, odds
ratios for cases vs controls of having a particular genotype; Pop control, cord blood population control samples.
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group, this should be considered an exploratory analysis that
encourages further investigations in other populations with
larger sample sizes.
KIR and HLA-C alleles show significant association with
malaria infection and severity
We sequenced HLA-C and -B alleles from 382 and 148
samples, respectively, and compared their frequencies across
groups as shown in Table 4. We found HLA-Cw*16:01 fre-
quency (a C group 1 allele) to be lowest amongst chil-
dren with severe malaria (P = 0.007, for comparison across
three groups, P = 0.077 after adjustment for multiple com-
parisons). This observation, however, should be taken with
caution given the small number of individuals used in this
comparison. None of the HLA-B alleles was found to have
any impact on malaria in this population. The frequencies of
HLA-B or -C dimorphic groups and subgroups (Bw4, Bw6,
Bw4-80I, Bw4-80T, C1, C2, C1/C2) were similar between
groups (Table 4).
It has been shown that KIR and HLA interact in an epistatic
manner to modulate human immunodeficiency virus (HIV)
disease outcome (29). In this study, we grouped individuals
based on whether they have corresponding putative ligand(s)
for their KIR genes. Analysis of KIR–HLA compound geno-
types as given in Table 4 showed significant differences in
the proportion of individuals carrying either KIR2DL2 and/or
KIR2DS2 together with their corresponding ligands [HLA-
C group 1 (C1)]. The frequencies of these two compound
genotypes were significantly higher in cases compared with
population control (P ≤ 2 × 10−4; adjusted for ethnicity
and multiple testing P ≤ 0.0008 for both comparisons), sug-
gesting that carriers of KIR2DL2+C1 and/or KIR2DS2+C1
were more at risk of being infected with malaria parasites
than those without any of these genotypes. However, these
two genes are in strong linkage disequilibrium (LD) even
in African populations (47, 48) making it difficult to know
which of them is actually mediating the effect. As earlier men-
tioned, future studies are needed to confirm this preliminary
observation.
The ratio of inhibitory to activating KIR genes and the
number of B motifs per KIR (B content) are associated
with level of parasitaemia
NK cell-derived IFN-γ has been proposed as an impor-
tant player of the innate immune response to malaria (10),
contributing to initial parasite control (49). Considering that
expression of KIR receptors on NK cells has been asso-
ciated with the magnitude of IFN-γ responses to malaria
parasites (14), we explored whether the ratio of inhibitory
over activating KIR genes (I/A ratio) or the carriage of
a particular KIR genotype is associated with parasite load
measured on admission. When the ratios were grouped into
four bins containing similar numbers of individuals, the
Table 4 HLA alleles and KIR–HLA compound genotypes on malariaa
Malaria cases
Allele∗
Uncomplicated
(%)
Severe
(%)
Pop
controls P
HLA-C
Cw*02 16 (16.3) 13 (22.4) 52 (23.0) 0.389
Cw*03 22 (22.5) 22 (37.9) 56 (24.8) 0.079
Cw*04 35 (35.7) 14 (24.1) 68 (30.1) 0.305
Cw*05:01 8 (8.2) 3 (5.2) 8 (3.5) 0.205 F
Cw*06:02 11 (11.2) 7 (12.1) 25 (11.1) 0.977
Cw*07 21 (21.4) 16 (27.6) 60 (26.6) 0.571
Cw*08 4 (4.1) 5 (8.6) 12 (5.3) 0.486 F
Cw*15 7 (7.1) 3 (5.2) 7 (3.1) 0.224 F
Cw*16:01 30 (30.6) 5 (8.6) 55 (24.3) 0.007
Cw*17 7 (7.1) 8 (13.8) 26 (11.5) 0.363
Cw*18 6 (6.1) 2 (3.5) 7 (3.1) 0.422 F
HLA-B
B*07 6 (14.0) 3 (11.5) 4 (5.1) 0.217 F
B*08:01 3 (7.0) 2 (7.7) 7 (8.9) 1.000 F
B*15 10 (23.3) 6 (23.1) 25 (31.7) 0.518
B*18:01 1 (2.3) 1 (3.9) 3 (3.8) 1.000 F
B*35:01 12 (27.9) 5 (19.2) 16 (20.3) 0.583
B*52:01 3 (7.0) 2 (7.7) 6 (7.6) 1.000 F
B*53 12 (27.9) 7 (26.9) 30 (38.0) 0.403
B*58 7 (16.3) 5 (19.2) 13 (16.5) 0.940
B*78 4 (9.3) 3 (11.5) 9 (11.4) 1.000 F
Group
Bw4 28 (65.1) 16 (61.5) 56 (70.9) 0.623
Bw4-80I 27 (62.8) 16 (61.5) 43 (54.4) 0.621
Bw6 32 (74.4) 18 (69.2) 58 (73.4) 0.888
C1 76 (77.6) 42 (72.4) 173 (76.6) 0.751
C2 70 (71.4) 36 (62.1) 144 (63.7) 0.343
C1C2 48 (49.0) 20 (34.5) 91 (40.3) 0.417
KIR–HLA
3DS1+Bw4 5 (11.6) 3 (11.5) 3 (3.8) 0.148 F
3DL1+Bw4 28 (65.1) 16 (61.5) 56 (70.9) 0.623
3DL1+Bw4-801 27 (62.8) 16 (61.5) 43 (54.4) 0.621
2DL2+C1 66 (67.4) 38 (65.5) 101 (44.7) <0.001
2DL3+C1 63 (64.3) 38 (65.5) 154 (68.1) 0.777
2DS2+C1 54 (55.1) 33 (56.9) 77 (34.1) <0.001
2DL1+C2 70 (71.4) 36 (62.1) 144 (63.7) 0.343
2DS1+C2 17 (17.4) 11 (19.0) 31 (13.7) 0.512
P, chi-squared or, where indicated, Fisher exact P-values comparing
the three groups, P-values that remained significant after adjustment
for ethnicity and correction for multiple comparisons (Bonferroni) are
printed in bold; ∗, two-digits results represent alleles with more than one
subtypes; Pop controls, population-based control samples.
aNumbers before the parenthesis indicate the number of individuals
positive for the genotype of interest. Rare alleles (present in less than
one percent of the studied population) are not included. HLA-C analysis
was based on data from 382 samples and HLA-B data was available for
148 individuals.
level of parasitaemia was significantly different (PANOVA =
0.03) showing a significant increase with increasing I/A ratio
(P test for linear trend = 0.009, Figure S2a). Further, indi-
viduals homozygous for KIR genotype A (A/A) had a 1.6-fold
higher geometric mean parasitaemia (Figure S2b) than those
with one or more B motif content (B/x) (P = 0.04), and
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Figure 2 Geometric mean parasitaemia levels according to the B
content of killer-cell immunoglobulin-like receptor (KIR) genotypes. Error
bars represent the 95% confidence interval (CI). Linear regression on
log transformed parasitaemia data indicates that parasitaemia declines
with increasing B content (P = 0.018, coefficient: −0.22 (95% CI: −0.4
to −0.04).
parasitaemia levels declined significantly with increasing B
content of the KIR genotype (P = 0.018, Figure 2).
Discussion
In this study, we determined the presence or absence of 15
KIR genes in two groups of children infected with the malaria
parasite P. falciparum with distinct disease outcomes (severe
malaria vs uncomplicated malaria) and in a population control
group. HLA class I (B and C) genotyping was performed on
a proportion of samples with enough genomic DNA left after
KIR typing. Possible KIR–HLA interactions were explored as
compound genotypes in individuals expressing KIR molecules
together with their putative ligand(s). Consistent with previous
studies in other West African populations (33, 48), we found
that the frequencies of inhibitory KIRs were significantly
higher overall compared with those of activating KIR genes
across disease entities and major ethnic groups represented in
the studied population. While the frequency of individual KIR
genes did not differ between severe and uncomplicated cases,
carriers of KIR2DL2, KIR2DS2 genes were more frequent
amongst cases (SM and UM combined) compared with the
population control group. Amongst the participants with
available HLA type individuals carrying either 2DL2 or 2DS2
together with their corresponding ligand (HLA-C group 1)
were significantly more frequent in the infected group. Taken
together, these observations suggest that these genes could be
involved in increased susceptibility to malaria infection caused
by P. falciparum. Although a few of our study participants
have one without the other, KIR2DL2 and 2DS2 genes are
in strong LD in most populations worldwide including those
of African origin (33, 48, 50). Because of the strong LD
between the two loci, it is difficult to separate the effect of
one locus from the other. The inhibitory KIR gene (2DL2)
and its corresponding activating counterpart (KIR2DS2 ) have
been associated with other diseases. Absence of these genes
has been associated with resistance to infection with herpes
simplex virus type-1 (HSV-1) (51). The presence of KIR2DS2
in the absence of its specific ligands has been associated
with increased susceptibility to psoriatic arthritis (30). On the
other hand, when both genes are present together with their
appropriate HLA-C ligands, they were associated with reduced
risk of chronic myeloid leukaemia (31).
Although the proportion of subjects with individual KIR
genes did not differ significantly between disease subgroups, it
is worth noting that prevalence of three activating KIR genes,
KIR2DS2, KR2DS5 and KIR3DS1 were highest in the most
critically ill children presenting with CM+SRD (Table S1).
While the relatively low number of children in each group
precludes firm conclusions, this observation is in line with
the finding that the predominantly inhibitory KIR genotype A
is virtually absent in the two groups of severe cases (SRD
and CM+SRD) that bear the highest mortality. Our data
also suggest that homozygosity for KIR genotype A (A/A)
might be protective against malaria infection, and that this
effect could mainly be associated with A/A homozygosity at
the centromeric segment of the KIR locus. Clearly, larger
studies are required to establish whether susceptibility to
malaria infection and/or mortality from severe disease is
associated with a higher frequency of a particular combination
of activating KIR genes or a relative absence of inactivating
KIR genes. If confirmed, this observation might be explained
by the concept of NK cell licensing (52), arming (53) or
education (54), whereby both tolerance to healthy cells as well
as the strength of the response of a mature NK cell towards an
infected cell are determined by the interactions between MHC
class I molecules and at least one expressed inhibitory KIR.
Accordingly, NK cells that show the strongest inhibition from
attacking healthy cells will most probably mount the strongest
responses towards infected cells (55). However, considering
that individuals homozygous for haplotype A (thus carrying
the ‘inhibitory’ KIR genotype A/A) produced significantly
less IFN-γ in response to stimulation with P. falciparum
antigens (14) it is plausible too that the predominance of
activating KIRs (or the relative absence of inhibitory KIRs)
contributes to exacerbated inflammatory responses that have
been implicated repeatedly in the pathogenesis of severe
malaria (13, 56). But, as our data suggest, the protective effect
of a predominantly inhibitory KIR (A/A genotype) may come
at the price of impaired NK-cell-mediated parasite clearance
during the early phase of infection.
Present in 6.4% and 12.5% of our population control sam-
ples and malaria cases respectively, KIR3DS1 was the least
frequent KIR gene in the Gambian population, in line with
previous data from other African populations (48, 50, 55).
Comparison of KIR gene evolution amongst different popu-
lations worldwide has suggested that KIR3DS1/L1 has been
under positive selection in modern Sub-Saharan African pop-
ulations, with KIR3DS1 being rare and KIR3DL1 allotypes
predominating (55). This would imply a biological benefit
derived from a low frequency of KIR3DS1, such as reduced
susceptibility to malaria or protection from severe forms
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of malaria, for which our data provide some support. In
a study that compared KIR genotypes in Melanesian indi-
viduals with and without malaria parasitaemia living in a
malaria hyper-endemic area KIR3DS1 positivity was equally
distributed in both groups, but KIR3DS1/L1 heterozygosity
was significantly associated with being parasite positive.
Taken together, our data provide some support for the
hypothesis that KIR genes influence susceptibility to malaria.
The involvement of genes located at the centromeric part of
the KIR locus in modulating the outcome of malaria and in
particular the role of KIR2DL2 and KIR2DS2 in the suscepti-
bility to P. falciparum malaria warrant further investigations,
and we recommend that larger studies should be performed
across different populations to test this hypothesis with addi-
tional power. Such studies are needed to complement genome-
wide approaches (42) that use single nucleotide polymorphism
analysis which is not designed to capture the extensive KIR
haplotypic diversity.
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